Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Vercellino

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Nanomaterials (Basel, Switzerland)|March 25, 2017
Nanostructured TiO₂ Surfaces Promote Human Bone Marrow Mesenchymal Stem Cells Differentiation to OsteoblastsMarco Vercellino, Gabriele Ceccarelli, Francesco Cristofaro, et al.
Journal of Neuroimmunology|March 30, 2023
Previous disease-modifying treatments influence T lymphocyte kinetics in people with multiple sclerosis switching to ocrelizumabGianmarco Abbadessa, Giuseppina Miele, Paola Cavalla, et al.
Biomaterials|December 10, 2013
Antibiofilm activity of a monolayer of silver nanoparticles anchored to an amino-silanized glass surfaceAngelo Taglietti, Carla Renata Arciola, Agnese D'Agostino, et al.
Brain Pathology (Zurich, Switzerland)|April 3, 2009
TDP-43 redistribution is an early event in sporadic amyotrophic lateral sclerosisMaria Teresa Giordana, Marco Piccinini, Silvia Grifoni, et al.
Journal of Neuroimmunology|June 10, 2008
Involvement of the choroid plexus in multiple sclerosis autoimmune inflammation: a neuropathological studyMarco Vercellino, Barbara Votta, Cecilia Condello, et al.
Multiple Sclerosis and Related Disorders|December 22, 2022
Association of vitamin D serum levels and vitamin D supplementation with B cell kinetics and disease activity in Multiple Sclerosis patients treated with ocrelizumab: an Italian multi-center studyGiuseppina Miele, Gianmarco Abbadessa, Paola Cavalla, et al.
Journal of Neuropathology and Experimental Neurology|June 16, 2009
Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matterMarco Vercellino, Silvia Masera, Marcella Lorenzatti, et al.
Multiple Sclerosis and Related Disorders|May 4, 2020
Assessing balance in non-disabled subjects with multiple sclerosis: Validation of the Fullerton Advanced Balance ScaleFabiola Giovanna Mestanza Mattos, Elisa Gervasoni, Denise Anastasi, et al.
International Journal of Molecular Sciences|February 27, 2013
Expression and Genetic Analysis of MicroRNAs Involved in Multiple SclerosisElisa Ridolfi, Chiara Fenoglio, Claudia Cantoni, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 14, 2021
Acute and chronic synaptic pathology in multiple sclerosis gray matterMarco Vercellino, Stella Marasciulo, Silvia Grifoni, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Nanomaterials (Basel, Switzerland)|March 25, 2017
Nanostructured TiO₂ Surfaces Promote Human Bone Marrow Mesenchymal Stem Cells Differentiation to OsteoblastsMarco Vercellino, Gabriele Ceccarelli, Francesco Cristofaro, et al.
Journal of Neuroimmunology|March 30, 2023
Previous disease-modifying treatments influence T lymphocyte kinetics in people with multiple sclerosis switching to ocrelizumabGianmarco Abbadessa, Giuseppina Miele, Paola Cavalla, et al.
Biomaterials|December 10, 2013
Antibiofilm activity of a monolayer of silver nanoparticles anchored to an amino-silanized glass surfaceAngelo Taglietti, Carla Renata Arciola, Agnese D'Agostino, et al.
Brain Pathology (Zurich, Switzerland)|April 3, 2009
TDP-43 redistribution is an early event in sporadic amyotrophic lateral sclerosisMaria Teresa Giordana, Marco Piccinini, Silvia Grifoni, et al.
Journal of Neuroimmunology|June 10, 2008
Involvement of the choroid plexus in multiple sclerosis autoimmune inflammation: a neuropathological studyMarco Vercellino, Barbara Votta, Cecilia Condello, et al.
Multiple Sclerosis and Related Disorders|December 22, 2022
Association of vitamin D serum levels and vitamin D supplementation with B cell kinetics and disease activity in Multiple Sclerosis patients treated with ocrelizumab: an Italian multi-center studyGiuseppina Miele, Gianmarco Abbadessa, Paola Cavalla, et al.
Journal of Neuropathology and Experimental Neurology|June 16, 2009
Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matterMarco Vercellino, Silvia Masera, Marcella Lorenzatti, et al.
Multiple Sclerosis and Related Disorders|May 4, 2020
Assessing balance in non-disabled subjects with multiple sclerosis: Validation of the Fullerton Advanced Balance ScaleFabiola Giovanna Mestanza Mattos, Elisa Gervasoni, Denise Anastasi, et al.
International Journal of Molecular Sciences|February 27, 2013
Expression and Genetic Analysis of MicroRNAs Involved in Multiple SclerosisElisa Ridolfi, Chiara Fenoglio, Claudia Cantoni, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 14, 2021
Acute and chronic synaptic pathology in multiple sclerosis gray matterMarco Vercellino, Stella Marasciulo, Silvia Grifoni, et al.
Pageof 5